Journal of Pharmacy and Pharmaceutical Research Open Access

Short Article

Photodynamic therapy: An emerging treatment modality for melanoma

• Surendra Lalwani

Short Article

Association of sepsis treatment of adult patients in the intensive care unit on severity index (APACHE) scores and clinical outcomes

• Khalid A Al-Sunaidar

Short Article

Preparation, optimization and evaluation of mucoadhesive microspreres of Stavudine

• Lalwani S

Short Article

Knowledge, attitude, and practice on human papilloma virus vaccination: A cross sectional study among university students

• Cervical cancer is the third most common cancer among women worldwide. Human Papillomavirus (HPV) is the main cause for cervical cancer as well as vulvar, vaginal, penile, anal and also oropharyngeal cancer. The burden of HPV-associated disease is still high across numerous countries regardless of the technological advancement in conveying information pertaining to the disease. Lack of awareness on HPV as well as misunderstandings on the risks associated with HPV vaccination can expose females to the disease and complications that arise from HPV.

Short Article

Scientific Evidence Supporting Benefits of Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015â??2017

• US Food and Drug Administration (FDA) exercises flexibility in the requirement that new drugs provide substantial evidence of benefit under the Food, Drug and Cosmetic Act. Provisions in law and policy provide numerous exceptions to the historical scientific standard of 2 or more controlled clinical trials demonstrating statistically significant evidence of benefit.